Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lindmark Bertil
Chief Medical Officer at Damora Therapeutics. Filing since 28 Jun 2021.
CIK 0001825778
Company
Date
Role
Action
Shares
Amount
Of holding
DMRA
Damora Therapeutics, Inc.
22 Mar 2022
Chief Medical Officer
Bought
14,604
$31.54K
730%
DMRA
Damora Therapeutics, Inc.
28 Jun 2021
Chief Medical Officer
Bought
2,000
$10.52K
opened
2 decisions on file.